Fiasp

by Novo Nordisk

Fiasp is a fast-acting mealtime insulin covered under Novo Nordisk's free patient assistance program for uninsured and underinsured patients.

Fiasp (insulin aspart injection) is a rapid-acting insulin used to control blood sugar spikes at mealtime in adults and children with diabetes. It starts working faster than standard insulin aspart (NovoLog), making it useful for people who need tighter postmeal glucose control. Fiasp is administered by subcutaneous injection just before or up to 20 minutes after starting a meal.

Patient assistance programs

Novo Nordisk Patient Assistance Program (NovoCare)

Manufacturer PAP
Eligibility
Adults and children with diabetes who are uninsured or underinsured and meet income requirements. Medicare Part D patients may qualify for insulin coverage through end of calendar year.
Income limit
≤400% of Federal Poverty Level (FPL)
Insurance
Uninsured or underinsured (Medicare Part D patients may qualify)
How to apply
Apply through ClariMeds — we handle all paperwork at no cost to you. Approval typically takes 2 business days once your application is complete.

Need help applying?

ClariMeds handles the entire application process for you — for free. See if you qualify in minutes.

See If You Qualify — Free